Close Menu

senior notes offering

NEW YORK (GenomeWeb News) – Qiagen said after the close of the market on Wednesday that it successfully completed the previously announced repurchase of convertible notes due in 2026 and the issuance

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today announced that it has priced $3.2 billion worth of senior notes that will help fund a portion of its pending $13.6 billion acquisition of Life Technologies

NEW YORK (GenomeWeb News) – Affymetrix said after the close of the market on Monday that it has given notice of its intention to redeem all of its outstanding 3.50 percent senior convertible notes due 2038.

NEW YORK (GenomeWeb News) – Sequenom today priced its private offering of $110 million of its 5 percent convertible senior notes due Oct. 1, 2017.

NEW YORK (GenomeWeb News) – Sequenom said after the close of the market on Monday it plans to offer $100 million in convertible senior notes due 2017.

NEW YORK (GenomeWeb News) – Agilent Technologies priced its public offering of senior notes at an aggregate principal amount of $400 million after the close of the market on Monday. The notes will mature in October 2022 and bear interest at an annual rate of 3.20 percent.

NEW YORK (GenomeWeb News) – Agilent Technologies today announced the offering of a series of senior notes.

NEW YORK (GenomeWeb News) – Laboratory Corporation of America after the close of the market Monday priced $1 billion of senior notes in two tranches.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has priced its $1.3 billion offering of senior notes, the firm announced after the close of the market yesterday.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it intends to offer senior notes to cover the cost of its $925 million acquisition of One Lambda.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.